NASDAQ : SRTA
Strata Critical Medical, Inc. — Key statistics
Healthcare · Medical Care Facilities · United States
Last price 4.44 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 392.79M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 392.79M |
| Enterprise Value | 374.29M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 3, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 88.47M |
| Shares Outstanding | 88.47M |
| Shares Change (YoY) | +6.59% |
| Shares Change (QoQ) | -4.39% |
| Owned by Insiders (%) | 14.28% |
| Owned by Institutions (%) | 47.44% |
| Float | 57.90M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 9.41 |
| Forward PE | 104.47 |
| PS Ratio | 1.53 |
| Forward PS | 1.25 |
| PB Ratio | 1.41 |
| P/TBV Ratio | 3.50 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 9.31 |
| EV / Sales | 1.46 |
| EV / EBITDA | 51.83 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.64 |
| Quick Ratio | 1.45 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.50 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -9.22% |
| Return on Assets (ROA) | -1.86% |
| Return on Invested Capital (ROIC) | -2.14% |
| Return on Capital Employed (ROCE) | -3.07% |
| Weighted Average Cost of Capital (WACC) | 17.43% |
| Revenue Per Employee | $782,798 |
| Profits Per Employee | $123,000 |
| Employee Count | 327 |
| Asset Turnover | 0.87 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 2.43 |
| 52-Week Price Change | -12.08% |
| 50-Day Moving Average | 5.10 |
| 200-Day Moving Average | 5.10 |
| Relative Strength Index (RSI) | 36.41 |
| Average Volume (20 Days) | 879,536 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 4.54M |
| Short Previous Month | 4.33M |
| Short % of Shares Out | 5.13% |
| Short % of Float | 7.84% |
| Short Ratio (days to cover) | 5.63 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 255.98M |
| Gross Profit | 54.40M |
| Operating Income | -8.81M |
| Pretax Income | -23.16M |
| Net Income | 40.22M |
| EBITDA | 7.22M |
| EBIT | -8.81M |
| Earnings Per Share (EPS) | $0.47 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 22.75M |
| Total Debt | 4.26M |
| Net Cash | 18.50M |
| Net Cash Per Share | $0.21 |
| Equity (Book Value) | 279.32M |
| Book Value Per Share | 3.16 |
| Working Capital | 75.23M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -36.03M |
| Capital Expenditures | -12.42M |
| Depreciation & Amortization | 16.03M |
| Net Borrowing | n/a |
| Free Cash Flow | -48.45M |
| FCF Per Share | -$0.55 |
Margins
| Measure | Value |
|---|
| Gross Margin | 21.25% |
| Operating Margin | -3.44% |
| Pretax Margin | -9.05% |
| Profit Margin | 15.71% |
| EBITDA Margin | 2.82% |
| EBIT Margin | -3.44% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -6.59% |
| Shareholder Yield | -6.59% |
| Earnings Yield | 10.62% |
| FCF Yield | -12.33% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $9.56 |
| Price Target Difference | 115.38% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 17.28% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 4.94 |
| Piotroski F-Score | 3 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |